$PATH
UiPath, Inc.

2021 Q2 Form 10-Q Financial Statement

#000156459021032266 Filed on June 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $186.2M $113.1M
YoY Change 64.64% 87.57%
Cost Of Revenue $49.01M $13.64M
YoY Change 259.36% -24.65%
Gross Profit $137.2M $99.47M
YoY Change 37.95% 135.7%
Gross Profit Margin 73.68% 87.94%
Selling, General & Admin $280.2M $117.6M
YoY Change 138.22% -22.06%
% of Gross Profit 204.19% 118.24%
Research & Development $93.04M $26.73M
YoY Change 248.09% -44.55%
% of Gross Profit 67.81% 26.87%
Depreciation & Amortization $1.800M $2.200M
YoY Change -18.18%
% of Gross Profit 1.31% 2.21%
Operating Expenses $373.2M $144.3M
YoY Change 158.57% -27.47%
Operating Profit -$236.0M -$44.87M
YoY Change 425.95% -71.38%
Interest Expense -$1.959M $500.0K
YoY Change -491.8% -16.67%
% of Operating Profit
Other Income/Expense, Net -$3.218M -$7.800M
YoY Change -58.74% 271.43%
Pretax Income -$238.3M -$52.18M
YoY Change 356.66% -67.02%
Income Tax $1.400M $662.0K
% Of Pretax Income
Net Earnings -$239.7M -$52.84M
YoY Change 353.56% -66.51%
Net Earnings / Revenue -128.7% -46.72%
Basic Earnings Per Share -$1.11
Diluted Earnings Per Share -$1.11 -$101.7K
COMMON SHARES
Basic Shares Outstanding 215.4M shares
Diluted Shares Outstanding 215.4M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.880B
YoY Change
Cash & Equivalents $1.796B $296.9M
Short-Term Investments $83.26M
Other Short-Term Assets $62.86M
YoY Change
Inventory
Prepaid Expenses $22.72M
Receivables $136.5M
Other Receivables $4.182M
Total Short-Term Assets $2.120B
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $15.15M
YoY Change
Goodwill $58.48M
YoY Change
Intangibles $20.42M
YoY Change
Long-Term Investments
YoY Change
Other Assets $14.54M
YoY Change
Total Long-Term Assets $186.7M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.120B
Total Long-Term Assets $186.7M
Total Assets $2.307B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.642M
YoY Change
Accrued Expenses $51.06M
YoY Change
Deferred Revenue $222.1M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $328.6M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $10.25M
YoY Change
Total Long-Term Liabilities $10.25M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $328.6M
Total Long-Term Liabilities $10.25M
Total Liabilities $407.0M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$1.210B
YoY Change
Common Stock $3.118B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.900B -$835.3M
YoY Change
Total Liabilities & Shareholders Equity $2.307B
YoY Change

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$239.7M -$52.84M
YoY Change 353.56% -66.51%
Depreciation, Depletion And Amortization $1.800M $2.200M
YoY Change -18.18%
Cash From Operating Activities -$17.52M -$24.13M
YoY Change -27.39%
INVESTING ACTIVITIES
Capital Expenditures $2.200M $460.0K
YoY Change 378.26%
Acquisitions $5.498M
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $10.87M -$460.0K
YoY Change -2463.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.443B 79.36M
YoY Change 1718.1%
NET CHANGE
Cash From Operating Activities -$17.52M -24.13M
Cash From Investing Activities $10.87M -460.0K
Cash From Financing Activities $1.443B 79.36M
Net Change In Cash $1.439B 62.73M
YoY Change 2193.39%
FREE CASH FLOW
Cash From Operating Activities -$17.52M -$24.13M
Capital Expenditures $2.200M $460.0K
Free Cash Flow -$19.72M -$24.59M
YoY Change -19.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-30
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
UiPath, Inc.
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001734722
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q2 dei Entity File Number
EntityFileNumber
001-40348
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4333187
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
90 Park Ave, 20th Floor
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10016
CY2021Q2 dei City Area Code
CityAreaCode
844
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
432-0455
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
22094000
CY2021Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
7000000
CY2021Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
83263000
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
102828000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
136520000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
172286000
CY2021Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
35058000
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
34221000
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20423000
CY2021Q2 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
13624000
CY2021Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
10653000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
41672000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14822000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
49752000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16490000
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
13500000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17260000
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Security12b Title
Security12bTitle
Class A common stock, par value $0.00001 per share
CY2021Q2 dei Trading Symbol
TradingSymbol
PATH
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1796267000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
357690000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
2119904000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
734430000
CY2021Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6500000
CY2021Q2 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
9136000
CY2021Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
2085000
CY2021Q2 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
44618000
CY2021Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
32553000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15149000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10191000
CY2021Q2 us-gaap Goodwill
Goodwill
58478000
CY2021Q1 us-gaap Goodwill
Goodwill
28059000
CY2021Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
7836000
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
8118000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14536000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12443000
CY2021Q2 us-gaap Assets
Assets
2306570000
CY2021Q1 us-gaap Assets
Assets
866461000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5642000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6682000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
51057000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
36660000
CY2021Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
49802000
CY2021Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
110736000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
222089000
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
211078000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
328590000
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
294257000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
365156000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
55224000
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
61325000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12968000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14152000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10247000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7564000
CY2021Q2 us-gaap Liabilities
Liabilities
407029000
CY2021Q1 us-gaap Liabilities
Liabilities
448197000
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
1221968000
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3117853000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
179175000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8294000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12521000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1210023000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-970360000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1899541000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-803704000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2306570000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
866461000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2137000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2879000
CY2021Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
CY2021Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0
CY2021Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
297973000
CY2021Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2021Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
294257000
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
186217000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
113103000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
49010000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
13638000
CY2021Q2 us-gaap Gross Profit
GrossProfit
137207000
CY2020Q2 us-gaap Gross Profit
GrossProfit
99465000
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
205751000
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
90931000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
93040000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26729000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
74415000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
159003000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26676000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
373206000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
144336000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-235999000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-44871000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
941000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
530000
CY2021Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
3218000
CY2020Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
7837000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-238276000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-52178000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1387000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
662000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-239663000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-52840000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.11
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
215352000
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-27000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4254000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
8313000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4227000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8313000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-235436000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44527000
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1971804000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
687903000
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
30446000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3114000
CY2021Q2 path Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options
AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExercisedStockOptions
1646000
CY2021Q2 path Adjustment To Additional Paid In Capital Tax Withholdings On Settlement Of Restricted Stock Units
AdjustmentToAdditionalPaidInCapitalTaxWithholdingsOnSettlementOfRestrictedStockUnits
-9218000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
252986000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-799511000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
536000
CY2020Q2 path Adjustments To Additional Paid In Capital Compensation Expense Related To Secondary Transactions
AdjustmentsToAdditionalPaidInCapitalCompensationExpenseRelatedToSecondaryTransactions
35000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8166000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-835301000
CY2021Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3172000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3147000
CY2021Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
4920000
CY2020Q2 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
8006000
CY2021Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
66000
CY2021Q2 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-558000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
250835000
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
8201000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1734000
CY2020Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1879000
CY2021Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-709000
CY2020Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29000
CY2021Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
21000
CY2020Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-52000
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35973000
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24132000
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
536000
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9769000
CY2021Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
8148000
CY2020Q2 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
4781000
CY2021Q2 path Increase Decrease In Capitalized Contract Cost
IncreaseDecreaseInCapitalizedContractCost
20205000
CY2020Q2 path Increase Decrease In Capitalized Contract Cost
IncreaseDecreaseInCapitalizedContractCost
5782000
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7666000
CY2020Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1109000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-528000
CY2020Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4251000
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4573000
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1646000
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-60433000
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8340000
CY2021Q2 path Increase Decrease In Operating Lease Liabilities Net
IncreaseDecreaseInOperatingLeaseLiabilitiesNet
-1807000
CY2020Q2 path Increase Decrease In Operating Lease Liabilities Net
IncreaseDecreaseInOperatingLeaseLiabilitiesNet
-1894000
CY2021Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4453000
CY2020Q2 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
14812000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17522000
CY2021Q2 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
94157000
CY2021Q2 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
89383000
CY2021Q2 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
23755000
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2200000
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
460000
CY2021Q2 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
410000
CY2021Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5498000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10873000
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-460000
CY2021Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
692369000
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2406000
CY2021Q2 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
750000000
CY2021Q2 path Payments Of Issuance Costs For Convertible Preferred Stock
PaymentsOfIssuanceCostsForConvertiblePreferredStock
164000
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3114000
CY2020Q2 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
78828000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1442913000
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
79364000
CY2021Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2313000
CY2020Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7955000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1438577000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
62727000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
371190000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
234131000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1809767000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
296858000
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
214000
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
368000
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3076000
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
455000
CY2021Q2 path Stock Based Compensation Capitalized For Software Development
StockBasedCompensationCapitalizedForSoftwareDevelopment
2151000
CY2021Q2 us-gaap Stock Issued1
StockIssued1
30446000
CY2021Q2 path Deferred Offering Costs Accrued But Not Yet Paid
DeferredOfferingCostsAccruedButNotYetPaid
1328000
CY2021Q2 path Reduction In Accrued Expenses And Other Liabilities For Vesting Of Early Exercised Stock Options
ReductionInAccruedExpensesAndOtherLiabilitiesForVestingOfEarlyExercisedStockOptions
1646000
CY2021Q2 path Tax Withholdings On Net Settlement Of Restricted Stock Units Accrued But Not Yet Paid
TaxWithholdingsOnNetSettlementOfRestrictedStockUnitsAccruedButNotYetPaid
9218000
CY2020Q2 path Deferred Payments Related To Business Acquisitions
DeferredPaymentsRelatedToBusinessAcquisitions
18269000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2870000
CY2021Q2 us-gaap Change In Accounting Principle Accounting Standards Update Transition Option Elected Extensible List
ChangeInAccountingPrincipleAccountingStandardsUpdateTransitionOptionElectedExtensibleList
path:AccountingStandardsUpdate202006RetrospectiveMember
CY2021Q2 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
CY2021Q2 us-gaap Fiscal Period
FiscalPeriod
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Fiscal Year</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:3.52%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our fiscal year ends on January 31. References to fiscal year 2022, for example, refer to the fiscal year ending January 31, 2022. </p>
CY2021Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:3.52%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts of assets and liabilities at the date of the condensed consolidated financial statements and the amounts of revenue and expenses reported during the period. We evaluate estimates based on historical and anticipated results, trends, and various other assumptions. Such estimates include, but are not limited to, revenue recognition, estimated expected benefit period for deferred contract acquisition costs, allowance for doubtful accounts, fair value of financial assets and liabilities including accounting and fair value of derivatives, fair value of acquired assets and assumed liabilities, useful lives of long-lived assets, capitalized software development costs, carrying value of operating lease right-of-use (&#8220;ROU&#8221;) assets, incremental borrowing rates for operating leases, amount of stock-based compensation expense including determination of fair value of common stock prior to the IPO, timing and amount of contingencies, and valuation allowance for deferred income taxes. Actual results could differ from these estimates and assumptions.</p>
CY2021Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Risks</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:3.52%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, marketable securities and accounts receivable. We maintain our cash balance at financial institutions that management believes are high-credit, quality financial institutions, where deposits, at times, exceed the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) limits. As of April&#160;30, 2021 and January 31, 2021, 99% and 92%, respectively, of our cash, cash equivalents, and restricted cash were concentrated in the United States, European Union (&#8220;EU&#8221;) countries, and Japan.</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:3.52%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We extend differing levels of credit to customers based on creditworthiness, do not require collateral deposits, and when necessary maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our customers by performing periodic evaluations of credit worthiness and applying other credit risk monitoring procedures.</p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:3.52%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant customers are those which represent 10% or more of our total revenue for the period or accounts receivable at the balance sheet date. For the three months ended April 30, 2021 and 2020, no single customer accounted for 10% or more of our total revenue. As of April 30, 2021 and January 31, 2021, no single customer accounted for 10% or more of our accounts receivable.</p>
CY2021Q2 path Entity Incorporation Month And Year
EntityIncorporationMonthAndYear
2015-06
CY2021Q2 us-gaap Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
29
CY2021Q2 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
2900000
CY2020Q2 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
7300000
CY2021Q2 us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2021Q2 us-gaap Revenue Practical Expedient Incremental Cost Of Obtaining Contract
RevenuePracticalExpedientIncrementalCostOfObtainingContract
true
CY2021Q2 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P5Y
CY2021Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2020Q2 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2021Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021Q2 path Capitalized Software Development Costs For Software Sold To Customers Estimated Useful Life
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomersEstimatedUsefulLife
P5Y
CY2021Q2 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
3400000
CY2021Q1 us-gaap Capitalized Software Development Costs For Software Sold To Customers
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers
2900000
CY2021Q2 path Capitalized Software Development Costs For Software Sold To Customers Amortization Expense
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomersAmortizationExpense
100000
CY2020Q2 path Capitalized Software Development Costs For Software Sold To Customers Amortization Expense
CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomersAmortizationExpense
100000
CY2021Q2 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
path:AccountingStandardsUpdate202006Member
CY2021Q2 us-gaap Change In Accounting Principle Accounting Standards Update Early Adoption
ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption
true
CY2021Q2 us-gaap Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
2021-02-01
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
19224000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1320000
CY2021Q2 path Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
220000
CY2021Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
30465000
CY2021Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-46000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1734000
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
81900000
CY2020Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
48300000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.63
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
463900000
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
83307000
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
102845000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2021Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
44000
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
24000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
83263000
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
102828000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
162000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
743000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
1996000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
11200000
CY2021Q1 us-gaap Goodwill
Goodwill
30465000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
44566000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
8460000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
36106000
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
24848000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4425000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20423000
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
13676000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3485000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10191000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
600000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4194000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5587000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5568000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3534000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
1879000
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
925000
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
3329000
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
125000
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
425000
CY2021Q2 us-gaap Lease Cost
LeaseCost
2784000
CY2020Q2 us-gaap Lease Cost
LeaseCost
5633000
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M18D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
5658000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7215000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4736000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1732000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
753000
CY2021Q2 path Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2000000
CY2021Q1 path Long Term Incentive Award Additional Commitment
LongTermIncentiveAwardAdditionalCommitment
3400000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6256000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5924000
CY2021Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
path:AccruedExpenseAndOtherCurrentLiabilities
CY2021Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
path:AccruedExpenseAndOtherCurrentLiabilities
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
22719000
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21302000
CY2021Q2 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
1749000
CY2021Q1 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
7178000
CY2021Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4182000
CY2021Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
4002000
CY2021Q2 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
13022000
CY2021Q1 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
17270000
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
34709000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
32886000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19560000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
18064000
CY2021Q2 us-gaap Depreciation
Depreciation
1800000
CY2020Q2 us-gaap Depreciation
Depreciation
2200000
CY2021Q2 path Accrued Expenses
AccruedExpenses
21396000
CY2021Q1 path Accrued Expenses
AccruedExpenses
11955000
CY2021Q2 path Accrued Tax Withholding For Share Based Compensation
AccruedTaxWithholdingForShareBasedCompensation
9218000
CY2021Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2326000
CY2021Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
2035000
CY2021Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1924000
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4022000
CY2021Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3969000
CY2021Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
8945000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5968000
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3779000
CY2021Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
3900000
CY2021Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
4100000
CY2021Q2 path Letters Of Credit Expire In Various Dates Through Fiscal Year
LettersOfCreditExpireInVariousDatesThroughFiscalYear
2022
CY2021 path Letters Of Credit Expire In Various Dates Through Fiscal Year
LettersOfCreditExpireInVariousDatesThroughFiscalYear
2022
CY2021Q2 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2021Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3100000
CY2020Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1900000
CY2021Q2 us-gaap Defined Contribution Plan Tax Status Extensible List
DefinedContributionPlanTaxStatusExtensibleList
us-gaap:QualifiedPlanMember
CY2020Q2 us-gaap Defined Contribution Plan Tax Status Extensible List
DefinedContributionPlanTaxStatusExtensibleList
us-gaap:QualifiedPlanMember
CY2021Q2 us-gaap Product Warranty Expense
ProductWarrantyExpense
0
CY2021Q2 us-gaap Product Liability Accrual Period Expense
ProductLiabilityAccrualPeriodExpense
0
CY2021Q2 path Long Term Incentive Award Additional Commitment
LongTermIncentiveAwardAdditionalCommitment
2900000
CY2021Q2 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
4844000
CY2021Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
12934000
CY2021Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
6556000
CY2021Q2 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
493000
CY2021Q2 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
3000
CY2021Q2 path Purchase Obligation Due After Fourth Year
PurchaseObligationDueAfterFourthYear
3000
CY2021Q2 us-gaap Purchase Obligation
PurchaseObligation
24833000
CY2021Q2 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
one-to-one basis,
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23013000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
147000
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1881000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
172000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21107000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
9925000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.58
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.10
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.26
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.32
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.59
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
1.04
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y6M
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y7M6D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1207831000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1486032000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
704260000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
55.91
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.25
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
101000000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
21800000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
250835000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8201000
CY2021Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2200000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.006
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.013
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0

Files In Submission

Name View Source Status
0001564590-21-032266-index-headers.html Edgar Link pending
0001564590-21-032266-index.html Edgar Link pending
0001564590-21-032266.txt Edgar Link pending
0001564590-21-032266-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
path-10q_20210430.htm Edgar Link pending
path-20210430.xml Edgar Link completed
path-20210430.xsd Edgar Link pending
path-20210430_cal.xml Edgar Link unprocessable
path-20210430_def.xml Edgar Link unprocessable
path-20210430_lab.xml Edgar Link unprocessable
path-20210430_pre.xml Edgar Link unprocessable
path-ex311_11.htm Edgar Link pending
path-ex312_10.htm Edgar Link pending
path-ex321_9.htm Edgar Link pending
path-ex322_8.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending